Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Corbus Pharmaceuticals Holdings Inc. (CRBP)

7.05   0.03 (0.43%) 06-19 16:00
Open: 7.04 Pre. Close: 7.02
High: 7.11 Low: 6.92
Volume: 799,808 Market Cap: 454M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.117 - 7.151 7.151 - 7.181
Low: 6.838 - 6.877 6.877 - 6.912
Close: 6.99 - 7.052 7.052 - 7.105

Technical analysis

as of: 2019-06-19 4:30:08 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 8.50     One year: 9.11
Support: Support1: 6.43    Support2: 5.35
Resistance: Resistance1: 7.27    Resistance2: 7.80
Pivot: 6.95
Moving Average: MA(5): 7.03     MA(20): 7.02
MA(100): 7.21     MA(250): 6.58
MACD: MACD(12,26): -0.05     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 70.68     %D(3): 62.12
RSI: RSI(14): 50.01
52-week: High: 9.11  Low: 4.50  Change(%): 17.5
Average Vol(K): 3-Month: 98305  10-Days: 68911

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CRBP has closed below upper band by 33.2%. Bollinger Bands are 60.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to CRBP's normal range. The bands have been in this narrow range for 54 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 04 Jun 2019 11:07:34 Z
Here's What Last Week's FDA CBD Hearing Really Means for Cannabis Stocks

Thu, 23 May 2019 14:09:08 Z
Is Corbus Pharmaceuticals a Buy Now?

Thu, 09 May 2019 19:57:40 Z
What You Need to Know About Corbus Pharmaceuticals' Q1 Earnings Update

Thu, 09 May 2019 18:58:01 Z
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q1 2019 Earnings Call Transcript

Thu, 09 May 2019 15:03:01 Z
Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Lags Revenue Estimates

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 64.46
Shares Float (M) 61.28
% Held by Insiders
% Held by Institutions 54.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.980
EPS Est. Current Year -0.640
EPS Est. Next Year -0.680
EPS Est. Next Quarter -0.180
Forward EPS -1.060
Book Value (p.s.) 10.060
PEG Ratio
Profit Margin
Operating Margin -1240.21
Return on Assets (ttm) -78.7
Return on Equity (ttm) -130.2
Qtrly Rev. Growth 98.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -18.15
Levered Free Cash Flow (M) 5.48

Stock Valuations

P/E -7.19
P/E Growth Ratio
P/BV 0.70
P/S 4544430080.00
P/CF -25.04

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.